APGE vs PTC · $2.34B cap vs P/E 48, rev $2.74B
Apogee Therapeutics, Inc. Common Stock (APGE) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
APGE does not have a complete income-statement cache yet.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
APGE currently screens at market cap $2.34B. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the APGE and PTC stock pages for the full models.
Not investment advice.